• Generated on:
    This page was generated by TSDR on 2026-09-23 07:20:39 EDT
    Mark:
    KITVI (BEZUCLASTINIB) TABLETS
    US Serial Number:
    50064173
    Application Filing Date:
    Aug. 21, 2026
    Filed as Base Application:
    Yes
    Currently Base Application:
    Yes
    Register:
    Principal
    Mark Type:
    Trademark
    TM5 Common Status Descriptor:
    TM5 Common Status image

    LIVE/APPLICATION/Awaiting Examination

    The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.

    Status:
    New application awaiting assignment to an examining attorney. See current trademark processing wait times for more information.
    Status Date:
    Aug. 21, 2026
     

    Mark Information

    Mark Literal Elements:
    KITVI (BEZUCLASTINIB) TABLETS
    Standard Character Claim:
    No
    Mark Drawing Type:
    3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S) /NUMBER(S)
    Description of Mark:
    The mark consists of The stylized words KITVI (BEZUCLASTINIB) TABLETS, all below a mountain design. The word KITVI is above the word (BEZUCLASTINIB), and the word TABLETS is below the word (BEZUCLASTINIB).
    Color(s) Claimed:
    Color is not claimed as a feature of the mark.
    Design Search Code(s):
    06.01.04 - Mountains (landscapes); Scenery with mountains
    26.05.15 - Four or more triangles; Triangles - four or more

    Goods and Services

    Note: The following symbols indicate that the registrant/owner has amended the goods/services:
    • Brackets [..] indicate deleted goods/services;
    • Double parenthesis ((..)) identify any goods/services not claimed in a Section 15 affidavit of incontestability; and
    • Asterisks *..* identify additional (new) wording in the goods/services.
    For:
    Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
    International Class(es):
    005 - Primary Class
    U.S Class(es):
    005, 006, 018, 044, 046, 051, 052
    Class Status:
    ACTIVE

    Basis Information (Case Level)

    Filed Use:
    No
    Currently Use:
    No
    Filed ITU:
    Yes
    Currently ITU:
    Yes
    Filed 44D:
    No
    Currently 44D:
    No
    Filed 44E:
    No
    Currently 44E:
    No
    Filed 66A:
    No
    Currently 66A:
    No
    Filed No Basis:
    No
    Currently No Basis:
    No

    Current Owner(s) Information

    Owner Name:
    Cogent Biosciences, Inc.
    Owner Address:
    180 Third Avenue, 4th Floor
    Waltham, MASSACHUSETTS UNITED STATES 02451
    Legal Entity Type:
    CORPORATION
    State or Country Where Organized:
    DELAWARE

    Attorney/Correspondence Information

    Attorney of Record
    Attorney Name:
    Gabriel M Gillmeyer
    Docket Number:
    120261-T-053
    Attorney Primary Email Address:
    Attorney Email Authorized:
    Yes
    Correspondent
    Correspondent Name/Address:
    Gabriel M Gillmeyer
    Ropes & Gray LLP
    Prudential Tower, 800 Boylston Street
    Boston, MASSACHUSETTS United States 02199-3600
    Phone:
    1-(617) 951-7374
    Correspondent e-mail:
    Correspondent e-mail Authorized:
    Yes
    Domestic Representative - Not Found

    Prosecution History

    Date Description Proceeding Number
    Aug. 21, 2026 APPLICATION FILING RECEIPT MAILED
    Aug. 21, 2026 NEW APPLICATION ENTERED

    TM Staff and Location Information

    TM Staff Information - None
    File Location
    Current Location:
    Not Found
    Date in Location:
    Not Found

    Assignment Abstract Of Title Information - Click to Load